Decreased TMPRSS2 expression by SARS-CoV-2 predicts the poor prognosis of lung cancer patients through metabolic pathways and immune infiltration

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread around the world and became a global pandemic in 2020. One promising drug target for SARS-CoV-2 is the transmembrane protease serine 2 (TMPRSS2). This study was designed to explore the expression status, prognostic signi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xiaopeng, Liu, Bing, Shang, Yanan, Cao, Pengxiu, Hou, Jiajie, Chen, Fei, Zhang, Bo, Fan, Yumei, Tan, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791221/
https://www.ncbi.nlm.nih.gov/pubmed/35017320
http://dx.doi.org/10.18632/aging.203823

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791221/
https://www.ncbi.nlm.nih.gov/pubmed/35017320
http://dx.doi.org/10.18632/aging.203823

Ejemplares similares